Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ALB NYSE:LTHM OTCMKTS:OROCF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALBAlbemarle$96.13+4.8%$80.37$49.43▼$113.91$11.30B1.653.58 million shs4.11 million shsLTHMLivent$16.51$16.24$12.76▼$29.17$2.97B1.7629.53 million shsN/AOROCFAllkem$6.80+1.5%$6.80$5.34▼$11.66N/A1.6814,560 shs1,900 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALBAlbemarle+1.16%+8.60%+11.88%+23.26%-8.56%LTHMLivent0.00%0.00%0.00%0.00%0.00%OROCFAllkem0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALBAlbemarle$96.13+4.8%$80.37$49.43▼$113.91$11.30B1.653.58 million shs4.11 million shsLTHMLivent$16.51$16.24$12.76▼$29.17$2.97B1.7629.53 million shsN/AOROCFAllkem$6.80+1.5%$6.80$5.34▼$11.66N/A1.6814,560 shs1,900 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALBAlbemarle+1.16%+8.60%+11.88%+23.26%-8.56%LTHMLivent0.00%0.00%0.00%0.00%0.00%OROCFAllkem0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALBAlbemarle 2.04Hold$87.35-9.13% DownsideLTHMLivent 0.00N/AN/AN/AOROCFAllkem 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest LTHM, ALB, BMW, and OROCF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/9/2025ALBAlbemarleCowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold10/9/2025ALBAlbemarleTD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$70.00 ➝ $85.0010/8/2025ALBAlbemarleWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/7/2025ALBAlbemarleZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy10/6/2025ALBAlbemarleUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$89.00 ➝ $85.0010/6/2025ALBAlbemarleJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$90.00 ➝ $105.0010/3/2025ALBAlbemarleMizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$78.00 ➝ $92.009/27/2025ALBAlbemarleWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/22/2025ALBAlbemarleHSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$60.00 ➝ $75.008/29/2025ALBAlbemarleRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetUnderperform$58.00 ➝ $68.00(Data available from 10/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALBAlbemarle$5.38B2.10$4.06 per share23.65$67.76 per share1.42LTHMLivent$813.20M3.65$1.73 per share9.55$8.04 per share2.05OROCFAllkem$1.21BN/A$1.10 per share6.16$8.96 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALBAlbemarle-$1.18B-$9.32N/A50.33N/A-18.61%-1.87%-0.89%11/5/2025 (Estimated)LTHMLivent$273.50M$1.799.2210.130.5140.77%25.60%18.40%N/AOROCFAllkem$441.71MN/A0.0042.50N/AN/AN/AN/AN/ALatest LTHM, ALB, BMW, and OROCF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/5/2025Q3 2025ALBAlbemarle-$0.97N/AN/AN/A$1.27 billionN/A7/30/2025Q2 2025ALBAlbemarle-$0.83$0.11+$0.94-$0.16$1.23 billion$1.33 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALBAlbemarle$1.621.69%N/AN/A 30 YearsLTHMLiventN/AN/AN/AN/AN/AOROCFAllkemN/AN/AN/AN/AN/ALatest LTHM, ALB, BMW, and OROCF DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/22/2025ALBAlbemarlequarterly$0.40502.13%9/12/20259/12/202510/1/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALBAlbemarle0.382.311.47LTHMLivent0.143.461.99OROCFAllkem0.082.522.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALBAlbemarle92.87%LTHMLivent96.76%OROCFAllkemN/AInsider OwnershipCompanyInsider OwnershipALBAlbemarle0.33%LTHMLivent1.17%OROCFAllkemN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALBAlbemarle8,300117.68 million117.30 millionOptionableLTHMLivent1,350179.73 million177.63 millionNot OptionableOROCFAllkem1,350N/AN/ANot OptionableLTHM, ALB, BMW, and OROCF HeadlinesRecent News About These CompaniesJefferies Keeps Their Hold Rating on Allkem Limited (OROCF)January 4, 2024 | markets.businessinsider.comJefferies Reaffirms Their Hold Rating on Allkem Limited (OROCF)December 27, 2023 | markets.businessinsider.comAllkem shareholders set to vote on Livent's $10.6 bln merger bidDecember 20, 2023 | sg.finance.yahoo.comSal de Vida Project Financing increases to US$180MDecember 14, 2023 | finance.yahoo.comSouth America's Lithium Potential Sparks Global Competition Amid Renewable Energy PushDecember 14, 2023 | baystreet.caAllkem Ltd OROCFNovember 12, 2023 | morningstar.comMAnalysts Offer Insights on Consumer Goods Companies: Allkem Limited (OtherOROCF), Silgan Holdings (SLGN) and Boston Beer (SAM)November 1, 2023 | markets.businessinsider.comHold Rating on Allkem Limited: Adjusted Estimates Amid Market Fluctuations and Cost ConcernsOctober 28, 2023 | markets.businessinsider.comOrocobre Limited (OROCF)October 13, 2023 | uk.finance.yahoo.comAnalysts Offer Insights on Consumer Goods Companies: Allkem Limited (OtherOROCF) and McDonald’s (MCD)September 26, 2023 | markets.businessinsider.comLivent: Lithium UpsideSeptember 25, 2023 | msn.comNickelSearch and Allkem collaborate to assess lithium potential at Carlingup; shares soarSeptember 15, 2023 | proactiveinvestors.com.auRBC Capital Sticks to Their Buy Rating for Allkem Limited (OROCF)August 24, 2023 | markets.businessinsider.comRBC Capital Sticks to Their Buy Rating for Allkem Limited (OROCF)August 24, 2023 | markets.businessinsider.comMacquarie Remains a Buy on Allkem Limited (OROCF)August 22, 2023 | markets.businessinsider.comBMO Capital Keeps Their Hold Rating on Allkem Limited (OROCF)August 22, 2023 | markets.businessinsider.comAllkem (OROCF) Price Target Increased by 8.92% to 11.87August 3, 2023 | msn.comAnalysts Offer Insights on Consumer Goods Companies: Mondelez International (MDLZ) and Allkem Limited (OtherOROCF)July 31, 2023 | markets.businessinsider.comRBC Capital Keeps Their Buy Rating on Allkem Limited (OROCF)July 31, 2023 | markets.businessinsider.comAllkem reports Q4 resultsJuly 28, 2023 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025The Fed Cut Rates: What Now for the S&P 500 and Equity Markets?By Thomas Hughes | September 18, 2025Why Datavault May Be the Penny AI Stock Investors Have Waited ForBy Nathan Reiff | September 22, 2025Is Qualcomm Tesla’s Next Rival in Autonomous Driving?By Sam Quirke | September 9, 2025Lithium Americas Rally Lifts Other Rare Earth Stocks By Gabriel Osorio-Mazilli | September 25, 2025LTHM, ALB, BMW, and OROCF Company DescriptionsAlbemarle NYSE:ALB$96.13 +4.44 (+4.84%) As of 02:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Specialties segment provides bromine-based specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; develops and manufactures cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies (CFT), which is composed of hydroprocessing catalysts (HPC) together with isomerization and akylation catalysts; fluidized catalytic cracking (FCC) catalysts and additives; and performance catalyst solutions (PCS), which is composed of organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.Livent NYSE:LTHMLivent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications. It also provides lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics; and lithium carbonate and lithium chloride for use as feedstock in the process of producing performance lithium compounds. The company was founded in 1940 and is headquartered in Philadelphia, Pennsylvania.Allkem OTCMKTS:OROCF$6.80 +0.10 (+1.49%) As of 01/8/2024Allkem Limited engages in the production and sale of lithium and boron in Argentina. Its flagship project is the Olaroz Lithium Facility located in Jujuy province in northern Argentina. Allkem Limited was incorporated in 2005 and is headquartered in Brisbane, Australia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AI Meets Nuclear: Palantir’s Role in Energy Expansion Adobe Launches Premiere Pro on iPhone, Upside Ahead? Rocket Lab: A Space Giant Hitting New Highs—Time to Chase? After AI Hyperscaler Deal, Is Aehr Test Systems Stock on Sale? Why Archer Aviation Stock Is Soaring—And What Comes Next Lithium Americas: Why This 31% Rally Is More Than Just a Headline Energy Transfer's New Growth Engine Ignites Investor Interest AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
